{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:36:13Z","timestamp":1785576973567,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":1311,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.5604\/16652681.1171778","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T11:36:58Z","timestamp":1443613018000},"page":"888-894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Drug-induced liver injury in hospitalized HIV patients: high incidence and association with drugs for tuberculosis"],"prefix":"10.1016","volume":"14","author":[{"given":"Lisia Gomes Martins de Moura","family":"Tomich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cassia","family":"Mendes-Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.5604\/16652681.1171778_bib0005","first-page":"921","article-title":"Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin","volume":"45","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.5604\/16652681.1171778_bib0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.qai.0000179459.31562.16","article-title":"Comparisons of causes of death and mortality rates among HIV-infected persons analysis of the pre-, early, and late HAART (Highly Active Antiretroviral Therapy) eras","volume":"41","author":"Crum","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.5604\/16652681.1171778_bib0015","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/QAI.0b013e3181a4ecf5","article-title":"Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil","volume":"51","author":"Pacheco","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.5604\/16652681.1171778_bib0020","first-page":"558","article-title":"Causes of death among people living with HIV\/AIDS in Brazil","volume":"14","author":"Rezende","year":"2010","journal-title":"Braz J Infect Dis"},{"key":"10.5604\/16652681.1171778_bib0025","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(10)62001-6","article-title":"Increasing burden of liver disease in patients with HIV infection","volume":"377","author":"Joshi","year":"2011","journal-title":"Lancet"},{"key":"10.5604\/16652681.1171778_bib0030","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.23716","article-title":"Clinical syndromes and consequences of antiretroviral-related hepatotoxicity","volume":"52","author":"N\u00fa\u00f1ez","year":"2010","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1171778_bib0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1086\/381444","article-title":"Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors","volume":"38","author":"Sulkowski","year":"2004","journal-title":"Clin Infec Dis"},{"key":"10.5604\/16652681.1171778_bib0040","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0399-8320(07)73987-8","article-title":"Foie et antir\u00e9troviraux: h\u00e9patotoxicit\u00e9, st\u00e9atose et monitoring en ca.s d\u2019h\u00e9patopathie","volume":"31","author":"Bourli\u00e8re","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.5604\/16652681.1171778_bib0045","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gut.2008.163675","article-title":"Diagnosis, management and prevention of drug-induced liver injury","volume":"58","author":"Verma","year":"2009","journal-title":"Gut"},{"key":"10.5604\/16652681.1171778_bib0050","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/342047","article-title":"Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 Study)","volume":"186","author":"Lewden","year":"2002","journal-title":"J Infect Dis"},{"key":"10.5604\/16652681.1171778_bib0055","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/00002030-200207050-00007","article-title":"Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?","volume":"16","author":"Rancinana","year":"2002","journal-title":"AIDS"},{"key":"10.5604\/16652681.1171778_bib0060","unstructured":"National Library of Medicine. LiverTox. Available from:http:\/\/livertox.nlm.nih.gov"},{"key":"10.5604\/16652681.1171778_bib0065","unstructured":"AIDS Clinical Trials Group. Table of grading severity of adult adverse experiences. Rockville, MD: Division of AIDS, National Institute of Allergy and Infectious Diseases; 1996."},{"key":"10.5604\/16652681.1171778_bib0070","unstructured":"FDA Guidance for Industry Drug-Induced Liver Injury: Premarketing Clinical Evaluation. Available from: <http:\/\/www.fda.gov\/downloads\/Drugs\/...\/Guidances\/UCM174090.pdf>;2009."},{"key":"10.5604\/16652681.1171778_bib0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2008.10.052","article-title":"Elevated serum alanine aminotransferase and gamma glutamyltransferase and mortality in the United States population","volume":"136","author":"Ruhl","year":"2009","journal-title":"Gastroenterol"},{"key":"10.5604\/16652681.1171778_bib0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1471-2334-9-205","article-title":"Early severe morbidity and resource utilization in South African adults on antiretroviral therapy","volume":"9","author":"de Cherif","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.5604\/16652681.1171778_bib0085","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1089\/aid.2006.22.825","article-title":"Impact of antiretroviral treatment-related toxicities on hospital admissions in HIV-infected patients","volume":"22","author":"N\u00fa\u00f1ez","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.5604\/16652681.1171778_bib0090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.qai.0000243054.58074.59","article-title":"Predictors of antiretroviral-related hepatotoxicity in the Adults AIDS Clinical Trial Group (1989-1999)","volume":"43","author":"Servoss","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.5604\/16652681.1171778_bib0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/341084","article-title":"Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy","volume":"186","author":"Wit","year":"2002","journal-title":"J Infect Dis"},{"key":"10.5604\/16652681.1171778_bib0100","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/QAD.0b013e32814e6b08","article-title":"Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B","volume":"21","author":"Hoffmann","year":"2007","journal-title":"AIDS"},{"key":"10.5604\/16652681.1171778_bib0105","doi-asserted-by":"crossref","first-page":"e40180","DOI":"10.1371\/journal.pone.0040180","article-title":"Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in Tanzania","volume":"7","author":"Mugusi","year":"2012","journal-title":"PLoS One"},{"key":"10.5604\/16652681.1171778_bib0110","doi-asserted-by":"crossref","first-page":"e94271","DOI":"10.1371\/journal.pone.0094271","article-title":"Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in Ethiopian patients","volume":"9","author":"Yimer","year":"2014","journal-title":"PLoS One"},{"key":"10.5604\/16652681.1171778_bib0115","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1590\/S0037-86822010000600004","article-title":"Antituberculosis drug-induced hepatotoxicity: a comparison between patients with and without human immunodeficiency virus seropositivity","volume":"43","author":"Coca","year":"2010","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.5604\/16652681.1171778_bib0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-008-9085-y","article-title":"A prospective study of antituberculous drug-induced hepatotoxicity in an area endemic for liver diseases","volume":"2","author":"Makhlouf","year":"2008","journal-title":"Hepatol Int"},{"key":"10.5604\/16652681.1171778_bib0125","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s10620-007-9999-6","article-title":"The Prevalence and Risk Factors for Abnormal Liver Enzymes in HIVPositive Patients without Hepatitis B or C Coinfections","volume":"53","author":"Sterling","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.5604\/16652681.1171778_bib0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1468-1293.2012.01006.x","article-title":"Elevated alanine aminotransferase in antiretroviral-na\u00efve HIV-infected African patients: magnitude and risk factors","volume":"13","author":"Nagu","year":"2012","journal-title":"HIV Med"},{"key":"10.5604\/16652681.1171778_bib0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1086\/588669","article-title":"Management of chronic hepatitis C virus infection in HIV-infected patients","volume":"47","author":"Pol","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.5604\/16652681.1171778_bib0140","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/QAD.0b013e328339e245","article-title":"Hospitalizations in a cohort of HIV patients in Australia, 1999-2007","volume":"24","author":"Falster","year":"2010","journal-title":"AIDS"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119309585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119309585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/publisherspanel.com\/icid\/pdf\/1171778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:34:55Z","timestamp":1761647695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119309585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1665268119309585"],"URL":"https:\/\/doi.org\/10.5604\/16652681.1171778","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced liver injury in hospitalized HIV patients: high incidence and association with drugs for tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/16652681.1171778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}